From Roche’s $1.4 billion licensing deal to AstraZeneca’s presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe’s leading cancer conference over the ...

Antibody–drug conjugates (ADCs) in oncology have been some of the most sought-after assets in the biopharma dealmaking landscape in the past two years. For example, in 2023, Pfizer purchased Seagen, ...

7MW4911, a CDH17-targeting ADC, received FDA IND clearance for Phase I/II trials in advanced colorectal and GI tumors, addressing significant unmet needs. The ADC uses Mabwell's IDDC™ platform, ...

Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...

Many noise sources can plague high-speed radio-frequency (RF) analog signal chains, making design considerations that much more challenging. Both megahertz and sub-terahertz sampling-rate converters ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

Forbes contributors publish independent expert analyses and insights. I track enterprise software application development & data management. Platforms dominate technology. We talk about Microsoft’s ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

Billionaire Elon Musk’s Department of Government Efficiency has a key ally in the US Department of the Treasury: Tom Krause, a veteran technology executive who’s now a special government employee, or ...

Citrix Netscaler is the latest target in widespread password spray attacks targeting edge networking devices and cloud platforms this year to breach corporate networks. In March, Cisco reported that ...